1. Stocks
  2. Fermenta Biotech Ltd.
  3. Swot
swot-logo

Fermenta Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Fermenta Biotech Ltd. has 22 Strengths, 10 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Newly Affordable Stocks with Good Financials and Durability (subscription)

Undervalued Growth Stocks

Jim Slater's Zulu Principle (Discover Growth Stocks)

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock with Low PE (PE < = 10)

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Declining Revenue every quarter for the past 2 quarters

Declining profits every quarter for the past 2 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Bullish or Bearish Candlestick Strength - Indices

Bullish Harami (Bullish Reversal)

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Declining Net Cash Flow and Cash from Operating Activity for last 2 years

Decline in Net Profit with falling Profit Margin (QoQ)